Companies House is rate-limiting or unreachable right now, so this page is showing the last data we hold on file. Officers, charges and filing history may be missing or out of date — refresh in a few minutes for live figures.
ADENDRA THERAPEUTICS LIMITED
- · Lifecycle stage: early → zombie
- · Investment thesis: growth_story → zombie_hold
- · Opportunity score: 76 → 67
- · Hygiene score: 90 → 80
- · Lifecycle stage drifting downward
- · Currently "zombie"
Picture worsened over the last 30 days — 4 negative signals vs 1 positive.
- ↓Lifecycle stage: early → zombie
- ·Investment thesis: growth_story → zombie_hold
- ↓Opportunity score: 76 → 67
- ↓Hygiene score: 90 → 80
- ↑Live charges: 2 → 0
- +2 more
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 67/100 (strong), bankability 70/100. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -52% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: distressed disposal / insolvency (65/100).
Data confidence
Overall: low (47/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £460.3k | £988.0k |
| Current assets | £473.2k | £1.28M |
| Cash | £374.7k | £778.1k |
| Debtors | £98.5k | £499.2k |
| Net assets | £-383.0k | £177.1k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Corporate timeline (1 events)Click to expand
- 2021-08-10🏢Company incorporatedAs ADENDRA THERAPEUTICS LIMITED
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
Red flags
cleanSimilar companies
Active · Professional services · EN postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A. LALJI LTD→ 10128273 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ACESO HEALTHCARE RECRUITMENT LIMITED→ 11171524 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| AEONN LTD→ 15777097 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AFRICAN STARTUP PORTFOLIO LTD→ 16022651 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AIBORN SOLUTIONS LTD→ 16000123 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AIM4ALL (SERVICES) LIMITED→ 15025283 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AJH HARDY (UK) LIMITED→ 11884522 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AKS STUDIOS LTD→ 15630196 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AKTT LTD→ 09511989 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AKYOL LAW LTD→ 11500038 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ALAB LTD→ 08880290 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ALAN BOOTH COMMISSIONING LIMITED→ 08447236 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →